TDM Guided Early Optimization of ADAL in Crohn's Disease
common.study.values.description
“TDM Guided Early Optimization of ADAL in Crohn's Disease”
To investigate the influence of early therapeutic drug monitoring and dose optimization on disease outcome in Crohn's patients treated with Adalimumab.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods


Biological - Adalimumab
participant.views.study.view.additional
participant.views.study.view.scientific-title
Therapeutic Drug Monitoring Guided Early Optimization of Adalimumab in Crohn's Disease; A Randomized Open Label Study
common.study.values.clinical-trial-id
NCT03261102
participant.views.study.view.id
mbk4xd